Legal Representation
Attorney
C. G. Mersereau
USPTO Deadlines
Next Deadline
645 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on R.PRA event 2017-09-26)
Due Date
September 26, 2027
Grace Period Ends
March 26, 2028
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 5, 2024 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Jul 24, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 26, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 25, 2017 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 24, 2017 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 5, 2017 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 10, 2017 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 4, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 10, 2017 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 28, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 3, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 3, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 14, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 14, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 14, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 14, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 14, 2016 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 14, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 3, 2016 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Aug 2, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 1, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Pseudo Mark
DR ONE